Comparing acute normovolumic hemodilution with autologous platelet-rich plasma for blood preservation during aortic surgery : study protocol for a randomized controlled clinical trial.
Acute normovolumic hemodilution
Autologous platelet-rich plasma
Postoperative blood drainage volume
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
18 Nov 2023
18 Nov 2023
Historique:
received:
09
12
2022
accepted:
10
11
2023
medline:
20
11
2023
pubmed:
19
11
2023
entrez:
19
11
2023
Statut:
epublish
Résumé
Both acute normovolumic hemodilution (ANH) and autologous platelet-rich plasma (aPRP) have been demonstrated blood-protective effects in cardiac aortic surgery; however, the efficacies of the two methods have not been compared. This study aims to compare the effects of aPRP and ANH prior to aortic surgery on postoperative bleed and other outcomes. This is a prospective, single-center, double-blind controlled clinical trial including 160 patients randomized 1:1 to receive aPRP (test group) or autologous whole blood (ANH, control group). The primary objective is to compare the drainage volumes in the two groups at 24, 48, and 72 h postoperatively. Secondary outcomes include input of allogeneic blood and blood products and durations of aortic block, extracorporeal circulation, deep hypothermic arrest of circulation, tracheal extubation, hospital stay, requirement for secondary surgical hemostasis, and application of intra-aortic balloon pump or extracorporeal membrane oxygenation in the two groups. In addition, heart rate, systolic blood pressure, diastolic blood pressure, central venous pressure, and thromboelastography recorded before blood reservation (T1), after blood reservation (T2), before blood transfusion (T3), and after the blood is returned (T4) to the transfusion will be compared between the two groups of patients. This study will demonstrate if the use of aPRP could reduce the risk of bleeding after aortic surgery compared with ANH. The results are expected to have practical clinical applications in terms of more effective blood protection and shorter hospital stay. This study was registered with the Chinese Clinical Trial Registry ( http://www.chictr.org.cn/ ) with the ID ChiCTR 1900023351.Registered on May 23, 2019. Recruiting start date: July 1, 2019; expected recruiting end date: July 1, 2024 Version number and date: Version 2 of 05-04-2019.
Sections du résumé
BACKGROUND
BACKGROUND
Both acute normovolumic hemodilution (ANH) and autologous platelet-rich plasma (aPRP) have been demonstrated blood-protective effects in cardiac aortic surgery; however, the efficacies of the two methods have not been compared. This study aims to compare the effects of aPRP and ANH prior to aortic surgery on postoperative bleed and other outcomes.
METHODS AND ANALYSIS
METHODS
This is a prospective, single-center, double-blind controlled clinical trial including 160 patients randomized 1:1 to receive aPRP (test group) or autologous whole blood (ANH, control group). The primary objective is to compare the drainage volumes in the two groups at 24, 48, and 72 h postoperatively. Secondary outcomes include input of allogeneic blood and blood products and durations of aortic block, extracorporeal circulation, deep hypothermic arrest of circulation, tracheal extubation, hospital stay, requirement for secondary surgical hemostasis, and application of intra-aortic balloon pump or extracorporeal membrane oxygenation in the two groups. In addition, heart rate, systolic blood pressure, diastolic blood pressure, central venous pressure, and thromboelastography recorded before blood reservation (T1), after blood reservation (T2), before blood transfusion (T3), and after the blood is returned (T4) to the transfusion will be compared between the two groups of patients.
DISCUSSION
CONCLUSIONS
This study will demonstrate if the use of aPRP could reduce the risk of bleeding after aortic surgery compared with ANH. The results are expected to have practical clinical applications in terms of more effective blood protection and shorter hospital stay.
TRIAL REGISTRATION
BACKGROUND
This study was registered with the Chinese Clinical Trial Registry ( http://www.chictr.org.cn/ ) with the ID ChiCTR 1900023351.Registered on May 23, 2019.
TRIAL STATUS
METHODS
Recruiting start date: July 1, 2019; expected recruiting end date: July 1, 2024 Version number and date: Version 2 of 05-04-2019.
Identifiants
pubmed: 37980486
doi: 10.1186/s13063-023-07800-4
pii: 10.1186/s13063-023-07800-4
pmc: PMC10657030
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
741Informations de copyright
© 2023. The Author(s).
Références
Ann Thorac Surg. 2015 Apr;99(4):1282-90
pubmed: 25661906
Am J Respir Crit Care Med. 2019 Apr 15;199(8):952-960
pubmed: 30407838
J Thorac Cardiovasc Surg. 2020 Jun;159(6):2288-2297.e1
pubmed: 31519411
Eur J Cardiothorac Surg. 2003 Jun;23(6):1023-7; discussion 1027
pubmed: 12829082
J Extra Corpor Technol. 2017 Dec;49(4):283-290
pubmed: 29302119
Cell Prolif. 2021 Dec;54(12):e13123
pubmed: 34609779
PLoS One. 2023 Aug 17;18(8):e0290384
pubmed: 37590313
Anaesthesist. 2012 Oct;61(10):846-56
pubmed: 22971923
Ann Thorac Surg. 2013 May;95(5):1525-30
pubmed: 23245451
Scand Cardiovasc J. 2012 Aug;46(4):194-202
pubmed: 22375889
Anesth Analg. 1995 Aug;81(2):229-35
pubmed: 7618707
Platelets. 2016 Dec;27(8):751-757
pubmed: 27164510
Jpn J Thorac Cardiovasc Surg. 2000 Nov;48(11):708-12
pubmed: 11144090
Anesth Analg. 2017 Mar;124(3):743-752
pubmed: 27669554
Cochrane Database Syst Rev. 2003;(2):CD004172
pubmed: 12804502
Eur J Cardiothorac Surg. 2003 Jul;24(1):119-24; discussion 124
pubmed: 12853055